Limited Effect of Chronic Valproic Acid Treatment in a Mouse Model of Machado-Joseph Disease.
Machado-Joseph disease (MJD) is an inherited neurodegenerative disease, caused by a CAG repeat expansion within the coding region of ATXN3 gene, and which currently lacks effective treatment. In this work we tested the therapeutic efficacy of chronic treatment with valproic acid (VPA) (200mg/kg), a...
Main Authors: | Sofia Esteves, Sara Duarte-Silva, Luana Naia, Andreia Neves-Carvalho, Andreia Teixeira-Castro, Ana Cristina Rego, Anabela Silva-Fernandes, Patrícia Maciel |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4624233?pdf=render |
Similar Items
-
Motor uncoordination and neuropathology in a transgenic mouse model of Machado–Joseph disease lacking intranuclear inclusions and ataxin-3 cleavage products
by: Anabela Silva-Fernandes, et al.
Published: (2010-10-01) -
Trehalose alleviates the phenotype of Machado–Joseph disease mouse models
by: Magda M. Santana, et al.
Published: (2020-04-01) -
Machado-Joseph Disease
by: J Gordon Millichap
Published: (1996-06-01) -
Machado-Joseph Disease
by: J Gordon Millichap
Published: (1994-10-01) -
GST-4-Dependent Suppression of Neurodegeneration in C. elegans Models of Parkinson’s and Machado-Joseph Disease by Rapeseed Pomace Extract Supplementation
by: Franziska Pohl, et al.
Published: (2019-10-01)